logo

For the Inventor, By the Inventor

Rochelle Park, NJ, United States of America

Kristine L Ogozalek

This inventor holds 7 USPTO granted patents. Top assignees: H. Lundbeck A/s, Synaptic Pharmaceutical Corporation. Active years: 2002-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristine L Ogozalek. Retrieved from https://idiyas.com/inventor/kristine-l-ogozalek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 28.6

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal6 out of 513 
 
H. Lundbeck A/s
 patents
silverMedal1 out of 126 
 
Synaptic Pharmaceutical Corporation
 patents

Years Active: 2002-2009

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7517658 - Methods for preparing compositions using a SNORF33 receptor (2009-04-14),
2. 7371535 - Processes for determining compounds that interact with snorf33 receptor (2008-05-13),
3. 7037665 - Compositions comprising SNORF36 receptor compounds (2006-05-02),
4. 7029914 - DNA encoding SNORF36 receptors (2006-04-18),
5. 7029857 - Processes for obtaining compounds employing SNORF72 receptors (2006-04-18),
6. 6987005 - DNA encoding SNORF33 receptor (2006-01-17),
7. 6413731 - Methods of screening for compounds which bind to a human SNORF36A receptor (2002-07-02),

Title: The Innovative Contributions of Kristine L Ogozalek

Introduction

Kristine L Ogozalek is a notable inventor based in Rochelle Park, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of receptor research. With a total of 7 patents to her name, her work has advanced the understanding of mammalian SNORF33 receptors.

Latest Patents

Ogozalek's latest patents include groundbreaking inventions such as "Methods for preparing compositions using a SNORF33 receptor." This invention provides isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, and vectors comprising nucleic acid encoding these receptors. Additionally, it includes methods for isolating mammalian SNORF33 receptors and treating abnormalities linked to their activity. Another significant patent is "Processes for determining compounds that interact with SNORF33 receptor," which also focuses on the same receptor and its various applications in identifying agonists and antagonists.

Career Highlights

Throughout her career, Kristine has worked with prominent companies such as H. Lundbeck A/S and Synaptic Pharmaceutical Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to innovative research.

Collaborations

Some of her notable coworkers include Beth E Borowsky and Parul P Lakhlani. Their collaborative efforts have further enhanced the research and development of receptor-related technologies.

Conclusion

Kristine L Ogozalek's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in receptor research and its applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…